- 10 Things To Know About Fentanyl, The Potentially Deadly Drug
- How Cities Are Expanding Opioid Use Disorder Treatment
- How The Americans With Disabilities Act Could Change The Way The Nation’s Jails And Prisons Treat Addiction
- Opioid Addicts Are Overdosing on Diarrhea Drug
- The Opioid Epidemic’s Disproportionate Effect On Middle-Aged Women
- Commonly Prescribed Meds for Treating Addiction Also Reduce Crime and Suicide
- What You Need To Know About Sleep Medications, Their Side Effects And Other Issues
- Struggling With Addiction? Tips On Finding Quality Treatment
- How Racial Bias Has Shaped the Opioid Epidemic
- 60% fewer insurers cover opioid addiction drugs now than in 2007 – but almost all cover the painkillers fueling the overdose epidemic, study finds
- Want a Better PDMP? Researchers, States are Working on
“In 2016, the powerful drug fentanyl claimed the life of music legend Prince and has, in recent years, largely contributed to the next wave of America’s opioid crisis.
Here are 10 things you should know about fentanyl.”
Source: Medicalpress.com – January 30, 2019
“On January 25, The Pew Charitable Trusts convened public health officials from Philadelphia, Pittsburgh, Cincinnati, and New York as well as providers from three Philadelphia care settings to share their insights and experiences related to medication-assisted treatment (MAT) for opioid use disorder.
More than 47,000 Americans died of opioid overdoses in 2017, and virtually no community has been spared from this public health crisis. Philadelphia alone recorded 1,217 accidental drug deaths that year—88 percent of which involved opioids.
In response, many communities are striving to make effective treatments more accessible. MAT, which combines Food and Drug Administration-approved medications with behavioral therapies, is considered the gold standard of care, as it is the most effective intervention to treat opioid use disorder (OUD).
As the speakers at the Jan. 25 event in Philadelphia discussed the current policy and treatment landscapes, and what they need to increase MAT access in their cities, three key takeaways emerged:”
- Integrated, coordinated treatment for OUD is essential
- Stigma associated with MAT may keep people from accessing evidence-based treatment
- Access to FDA-approved medications is a public health imperative
Source: PewTrusts.org – February 6, 2019
How The Americans With Disabilities Act Could Change The Way The Nation’s Jails And Prisons Treat Addiction
“Before Geoffrey Pesce got on methadone, his addiction to heroin and oxycodone nearly destroyed him: He lost his home, his job, custody of his son—and his driver’s license. So even after he began to rebuild his life, Pesce relied on his parents to drive him to a methadone clinic for his daily dose. One day last July, his mother was unexpectedly unavailable, and desperate not to relapse, he drove himself.
En route, Pesce was pulled over for going 6 miles above the speed limit and charged with driving with a suspended or revoked license, which carries at least 60 days in jail. Pesce began staring down the day he would plead guilty and, as mandated by the rules of the jail in Essex County, Massachusetts, stop taking the addiction drug that he said saved his life.”
Source: ABA Journal – February 8, 2019
“A popular anti-diarrheal drug is fast becoming another dangerous byproduct of the opioid crisis, as more addicts take huge quantities of it to ease withdrawal symptoms or get dangerously high.
Investigators found that the number of patients who were reported to the U.S. National Poison Data System after taking toxic doses of loperamide (one over-the-counter brand is Imodium) skyrocketed by more than 90 percent between 2010 and 2016.
Why the jump? The primary appeal of loperamide is that while it has an opioid-like effect on bowel movements and doesn’t produce a high in recommended doses, it can make someone high in huge quantities.”
Source: USNews.com – February 7, 2019
“Whether it’s death from opioid overdoses or heart attacks, there are health issues that impact women more than men.
Per the CDC, about 18 women die every day in the U.S. from a prescription painkiller overdose.
Research has found that women are more sensitive to the effects of certain drugs, including opioids, due to their hormones. This is applicable to heart disease as well; for instance, heart disease is more common in women after menopause, which is thought to be related to a decrease in female hormones.
Despite death by drug overdose being classically thought of as more common in men, this gap between men and women is closing. The latest CDC report showed that middle-aged women in particular are now increasingly affected.
In fact, the report highlighted that death by drug overdose has increased in women ages 30-64 by 260 percent from 1999 to 2017.”
Source: Bloga.bcm.edu – February 6, 2019
“This is the Medscape Psychiatry Minute. I’m Dr Peter Yellowlees.
The use of medication-assisted treatment for addictions is becoming increasingly common. However, we don’t know whether there are associations between medications for alcohol and opioid use disorders (acamprosate, naltrexone, methadone, and buprenorphine) and suicidal behavior, accidental overdoses, and crime.
Now a team of investigator] from the University of Oxford, England, have investigated this question in a within-individual population cohort study of 21,281 individuals in Swedish registries who received treatment with at least one of these four medications between 2005 and 2013.
No significant associations were found for acamprosate, but for naltrexone there was a reduction in accidental overdoses. Buprenorphine was associated with reduced arrest rates for all crime categories, as well as a reduction in accidental overdoses. For methadone, there were significant reductions in the rate of suicidal behaviors as well as reductions in all crime categories. The authors concluded that medications currently used to treat alcohol and opioid use disorders also appear to reduce suicidality and crime during treatment.”
Read more at: https://www.medscape.com/viewarticle/907874
Source: Medscape.com – February 6, 2019
“A lot of people out there don’t get enough sleep — more than 1 in 3 American adults, according to the Centers for Disease Control and Prevention.
If you’re one of them, you probably know there are two main treatments for improving sleep: behavioral methods and medications.
When you’re desperate for a good night’s sleep, medications sure do sound appealing. But there are caveats with them all — the prescription pills, the over-the-counter products and the herbal supplements.
Before describing the medications in detail, I’ll remind you that the prevailing wisdom is that cognitive behavioral therapy, which involves changing habits and bedtime rituals, is the first-line treatment for insomnia. Sleep experts say CBT is more effective and longer lasting than medication for most people — but maybe you’re not most people.”
Read more at: https://www.washingtonpost.com/national/health-science/what-you-need-to-know-about-sleep-medications-their-side-effects-and-other-issues/2019/02/08/577d2e70-295f-11e9-984d-9b8fba003e81_story.html?utm_term=.3c3516480b2a
Source: WashingtonPost.com – February 9, 2019
“It can be overwhelming and confusing to know where to start if you need to find treatment for an alcohol or drug addiction. Addiction touches nearly everyone in some way, yet, like all health care, effective treatment must be tailored to the needs of the individual. With many addiction treatment options, finding a program that will provide the quality care you or your loved one needs to address the specific addiction issues can be challenging. These steps will help you know what to look for to find a treatment program that is high quality and tailored to your needs.”
Source: SAMHSA Blog – January 23, 2019
IMPLICIT BIASES IN doctor’s offices and elsewhere in health care are likely drivers behind stark racial and class divides in drug addiction and overdose deaths in California, a new study suggests.
While affecting people across race and ethnicity, the opioid crisis gripping the nation has been concentrated largely among low-income whites, and has been labeled a problem primarily of public health, not of criminal justice. The epidemic is thought to have been touched off by a combination of social factors – including trauma, poverty and a lack of economic opportunity – and the widespread availability of prescription opioids beginning in the 1990s.
The new study, published Monday in JAMA Internal Medicine, indicates the health care field has had a hand in driving the epidemic that goes beyond merely dispensing prescription drugs, suggesting that differing access to and within the system has resulted in rampant addiction among low-income whites as well as a sea of untreated pain in minority communities.
Source: US News.com – February 11, 2019
60% fewer insurers cover opioid addiction drugs now than in 2007 – but almost all cover the painkillers fueling the overdose epidemic, study findsThe number of people dying of opioid overdoses has surged since the 1990s
Medically-assisted treatments like buprenorphine are widely agreed to be the best therapies for addiction
Many insurance companies will not let patients access the drug for one to 15 days
In 2007, 89 percent of insurers covered buprenorphine without restrictions
By 2018, just 35 percent did so, new research from Oregon Health and Science University reveals
Source: DailyMail.co.uk – February 13, 2019
“Prescription drug monitoring programs could be more useful to physicians if their results were available in a more readable format, researchers said here.
The opioid epidemic continues to rage in the U.S., noted Scott Weiner, MD, MPH, attending physician at Brigham and Women’s Hospital in Boston. “For the second year in a row, life expectancy in the U.S. has dropped … We haven’t seen that since the AIDS epidemic, and it’s mainly contributed to by overdose deaths.”
To help find patients with a potential addiction problem, prescription drug monitoring programs (PDMPs) are now in use in 50 states, and prescriber use is mandated in many of those, Weiner said here at the annual meeting of the Healthcare Information and Management Systems Society (HIMSS).
But even though checking the PDMP is required, not all prescribers do so, said Jaya Tripathi, principal analyst for analytics at the MITRE Corporation in Bedford, Mass. A study conducted by her company in 2013 and revised in 2017 found that although 77% of responding physicians used an electronic health record, 22% said they didn’t log into a PDMP when prescribing opioids or other drugs that mandate its use.”
Read more at: https://www.medpagetoday.com/meetingcoverage/himss/77997
Source: MedPageToday.com – February 13, 2019